Status:
COMPLETED
Strategies of Interruption/Reinitiation of Antiretroviral Therapy in HIV-Infected Patients With Lipodystrophy
Lead Sponsor:
Hospital Clinic of Barcelona
Conditions:
HIV-Associated Lipodystrophy Syndrome
Eligibility:
All Genders
18+ years
Phase:
PHASE4
Brief Summary
Aim: To assess the safety on the progression of HIV infection and the efficacy on the evolution of metabolic parameters and body fat of either viral load- or CD4 cell-driven strategies of intermittent...
Eligibility Criteria
Inclusion
- HIV-infected patients
- On stable antiretroviral therapy
- Viral load below 200 copies/ml
- CD4 above 450 cells/mcl during last 3 months
Exclusion
- Weight variation higher than 10% compared with previous stable weight
- Active (CDC-C) opportunistic events
- Major depression or schizophrenia under psychiatric treatment
- Lack of clinical stability
- Pregnant women or planning pregnancy
Key Trial Info
Start Date :
January 1 2002
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 1 2006
Estimated Enrollment :
147 Patients enrolled
Trial Details
Trial ID
NCT00646984
Start Date
January 1 2002
End Date
April 1 2006
Last Update
March 31 2008
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hospital Clinic of Barcelona
Barcelona, Spain, 08036